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SCIENTIFIC OPINION  
Scientific Opinion on Flavouring Group Evaluation 303 (FGE.303): 
Spilanthol from chemical group 301 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)2, 3  
European Food Safety Authority (EFSA), Parma, Italy 
SUMMARY  
The Scientific Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (the 
Panel) was asked to provide scientific advice to the Commission on the implications for human health 
of chemically defined flavouring substances used in or on foodstuffs in the Member States. In 
particular, the Panel was requested to evaluate one flavouring substance in the Flavouring Group 
Evaluation 303, using the Procedure as referred to in the Commission Regulation (EC) No 1565/2000. 
The flavouring substance belongs to chemical group 30, Annex I of the Commission Regulation (EC) 
No 1565/2000. 
The candidate substance spilanthol [FL-no: 16.121] is a branched chain unsaturated aliphatic amide 
from chemical group 30. 
The substance has been presented with specification of the stereoisomeric composition. 
The candidate substance was assigned to structural class III, according to the decision tree approach 
presented by Cramer et al., 1978. 
According to the Flavour Industry spilanthol has been identified in the plant Spilanthes oleracea, 
which is used in some countries as a spice. 
In its evaluation, the Panel as a default used the “Maximised Survey-derived Daily Intake” (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe. However, when the 
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Panel examined the information provided by the European Flavouring Industry on the use levels in 
various foods, it appeared obvious that the MSDI approach in a number of cases would grossly 
underestimate the intake by regular consumers of products flavoured at the use level reported by the 
Industry, especially in those cases where the annual production values were reported to be small. In 
consequence, the Panel had reservations about the data on use and use levels provided and the intake 
estimates obtained by the MSDI approach.  
 
In the absence of more precise information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a “modified Theoretical Added Maximum Daily Intake” 
(mTAMDI) approach based on the normal use levels reported by Industry. In those cases where the 
mTAMDI approach indicated that the intake of a flavouring substance might exceed its corresponding 
threshold of concern, the Panel decided not to carry out a formal safety assessment using the 
Procedure. In these cases the Panel requires more precise data on use and use levels. 
 
Genotoxicity data are not available for the candidate substance spilanthol [FL-no: 16.121]. However, 
the Panel considers that the lack of genotoxicity data do not preclude the evaluation of this aliphatic 
amide by using the Procedure. 
The candidate substance cannot be anticipated to be metabolised to innocuous products. 
According to the default MSDI approach, the candidate substance in this group has an intake in 
Europe of 24 micrograms/capita/day [FL-no: 16.121]. For the candidate substance, this is below the 
threshold of concern value for structural class III (90 micrograms/person/day). 
When the estimated intake was based on the mTAMDI approach it is 830 micrograms/person/day for 
the candidate substance from structural class III, which is above the threshold of concern for structural 
III of 90 micrograms/person/day. Therefore more reliable exposure data are required. On the basis of 
such additional data, the flavouring substance should be reconsidered using the Procedure. 
Subsequently, additional data might become necessary. 
No relevant data on toxicity are available for the candidate substance or the three supporting 
substances. The only toxicity data available is a 28-day study which is not considered sufficient to 
evaluate chronic effects of the substance. Accordingly, additional data are required for the candidate 
substance. According to the practice of the Panel, a minimum requirement to provide an adequate 
NOAEL for flavourings in the Procedure is a 90-day study. 
In order to determine whether the conclusion for the candidate substance can be applied to the material 
of commerce, it is necessary to consider the available specifications. Adequate specifications including 
complete purity criteria and identity for the material of commerce have been provided for the 
flavouring substance.  
In conclusion, for the candidate substance spilanthol [FL-no: 16.121] additional data on chemical 
defined material are required as a 28 day study is not considered sufficient to deriving a NOAEL.  
 
KEY WORDS 
Flavouring, food safety, spilanthol, aliphatic amide. 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a). For the submission of data by the 
manufacturer, deadlines have been established by Commission Regulation (EC) No 622/2002 (EC, 
2002b).  
After the completion of the evaluation programme the Union List of flavouring substances for use in 
or on foods in the EU shall be adopted (Article 5 (1) of Regulation (EC) No 2232/96) (EC, 1996a). 
TERMS OF REFERENCE 
The European Food Safety Authority (EFSA) is requested to carry out a risk assessment on flavouring 
substances in the Register prior to their authorisation and inclusion in a Union List according to 
Commission Regulation (EC) No 1565/2000 (EC, 2000a). In addition, the Commission requested 
EFSA to evaluate newly notified flavouring substances, where possible, before finalising the 
evaluation programme. 
In addition, in letter of 28 January 2010 the Commission requested EFSA to carry out a risk 
assessment on Spilanthol [FL-no: 16.121] in accordance with Commission Regulation (EC) No 
1565/2000 (EC, 2000a): 
“The European Commission requests the European Food Safety Authority to carry out a safety 
assessment of two flavouring substances, Spilanthol and L-methionylglycine, in accordance with 
Commission Regulation (EC) No 1565/2000 (EC, 2000a) by end 2010”.   
The deadline of the Terms of Reference was negotiated to 31 May 2011. L-methionylglycine is 
evaluated in FGE.305. 
ASSESSMENT 
1. Presentation of the Substances in Flavouring Group Evaluation 303 
1.1. Description 
The present Flavouring Group Evaluation 303 (FGE.303), using the Procedure as referred to in the 
Commission Regulation (EC) No 1565/2000 (the Procedure – shown in schematic form in Annex I of 
this FGE), deals with one flavouring substance (candidate substance) from chemical group 30 of 
Annex I of Commission Regulation (EC) No 1565/2000 (EC, 2000a).  
The one candidate substance under consideration in the present evaluation, with its chemical Register 
name, FLAVIS- (FL-), Chemical Abstract Service- (CAS-), Council of Europe- (CoE-) and Flavor and 
Extract Manufacturers Association- (FEMA-) numbers, and structures is listed in Table 1.  
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The outcome of the safety evaluation is summarised in Table 2a. 
The hydrolysis products of the candidate substance are listed in Table 2b. 
The flavouring substance spilanthol [FL-no: 16.121] (candidate substance) is a branched chain 
unsaturated aliphatic amide and is closely related structurally to three flavouring substances 
(supporting substances) [FL-no: 16.091, 16.093 and 16.094] evaluated at the 65th JECFA meeting 
(JECFA, 2006d) in the group of “Aliphatic and aromatic amines and amides” and considered by the 
Panel in FGE.86Rev1. The names and structures of the supporting substances are listed in Table 3, 
together with their evaluation status. 
1.2. Stereoisomers 
It is recognised that geometrical and optical isomers of substances may have different properties. Their 
flavour may be different, they may have different chemical properties resulting in possible variability 
in their absorption, distribution, metabolism, elimination and toxicity. Thus, information must be 
provided on the configuration of the flavouring substance, i.e. whether it is one of the 
geometrical/optical isomers, or a defined mixture of stereoisomers. The available specifications of 
purity will be considered in order to determine whether the safety evaluation carried out for candidate 
substances for which stereoisomers may exist can be applied to the material of commerce. Flavouring 
substances with different configurations should have individual chemical names and codes (CAS 
number, FLAVIS number etc.). 
The candidate substance spilanthol [FL-no: 16.121] can exist as geometrical stereoisomers due to the 
presence of double bonds. The name spilantol specify the (2E,6Z,8E) geometric stereoisomer (see 
Table 1). According to Industry, [FL-no: 16.121] exists as a mixture of the geometrical stereoisomers. 
The stereoisomeric composition has been specified (Flavour Industry, 2009r) (see Table 1). 
1.3. Natural Occurrence in Food 
According to TNO, the candidate substance spilanthol [FL-no: 16.121] has not been reported to occur 
naturally in any food items (TNO, 2010). 
Spilanthol has been identified in Spilanthes oleracea, which according to Flavour Industry is used as a 
spice in some countries (Molinatorres et al., 1996; Yasuda et al., 1980; Ramsewak et al., 1999).  
2. Specifications 
Purity criteria for the candidate substance have been provided by the Flavour Industry (Flavour 
Industry, 2009r) (Table 1). 
Judged against the requirements in Annex II of Commission Regulation (EC) No 1565/2000 (EC, 
2000a), this information is adequate for the candidate substance (see Section 1.2 and Table 1). 
3. Intake Data 
Annual production volumes of the flavouring substances as surveyed by the Industry can be used to 
calculate the “Maximised Survey-derived Daily Intake” (MSDI) by assuming that the production 
figure only represents 60 % of the use in food due to underreporting and that 10 % of the total EU 
population are consumers (SCF, 1999a). 
However, the Panel noted that due to year-to-year variability in production volumes, to uncertainties 
in the underreporting correction factor and to uncertainties in the percentage of consumers, the 
reliability of intake estimates on the basis of the MSDI approach is difficult to assess. 
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The Panel also noted that in contrast to the generally low per capita intake figures estimated on the 
basis of this MSDI approach, in some cases the regular consumption of products flavoured at use 
levels reported by the Flavour Industry in the submissions would result in much higher intakes. In 
such cases, the human exposure thresholds below which exposures are not considered to present a 
safety concern might be exceeded. 
Considering that the MSDI model may underestimate the intake of flavouring substances by certain 
groups of consumers, the SCF recommended also taking into account the results of other intake 
assessments (SCF, 1999a). 
One of the alternatives is the “Theoretical Added Maximum Daily Intake” (TAMDI) approach, which 
is calculated on the basis of standard portions and upper use levels (SCF, 1995) for flavourable 
beverages and foods in general, with exceptional levels for particular foods. This method is regarded 
as a conservative estimate of the actual intake by most consumers because it is based on the 
assumption that the consumer regularly eats and drinks several food products containing the same 
flavouring substance at the upper use level. 
One option to modify the TAMDI approach is to base the calculation on normal rather than upper use 
levels of the flavouring substances. This modified approach is less conservative (e.g., it may 
underestimate the intake of consumers being loyal to products flavoured at the maximum use levels 
reported) (EC, 2000a). However, it is considered as a suitable tool to screen and prioritise the 
flavouring substances according to the need for refined intake data (EFSA, 2004a). 
3.1. Estimated Daily per Capita Intake (MSDI Approach) 
The intake estimation is based on the Maximised Survey-derived Daily Intake (MSDI) approach, 
which involves the acquisition of data on the amounts used in food as flavourings (SCF, 1999a). These 
data are derived from surveys on annual production volumes in Europe. These surveys were conducted 
in 1995 by the International Organization of the Flavour Industry (IOFI), in which flavour 
manufacturers reported the total amount of each flavouring substance incorporated into food sold in 
the EU during the previous year (IOFI, 1995). The intake approach does not consider the possible 
natural occurrence in food. 
Average per capita intake (MSDI) is estimated on the assumption that the amount added to food is 
consumed by 10 % of the population4 (Eurostat, 1998). This is derived for candidate substances from 
estimates of annual volume of production provided by Industry and incorporates a correction factor of 
0.6 to allow for incomplete reporting (60 %) in the Industry surveys (SCF, 1999a). 
The anticipated total annual volume of production of the candidate substance spilanthol [FL-no: 
16.121] in the present Flavouring Group Evaluation (FGE.303) from use as flavouring substance in 
Europe has been reported to be approximately 200 kg (Flavour Industry, 2009r). For the supporting 
substances the total annual volume of production is 1000 kg in Europe (Flavour Industry, 2004f). 
On the basis of the annual volumes of production reported for the candidate substance, the daily per 
capita intake for the flavouring has been estimated. The estimated daily per capita intake of spilanthol 
[FL-no: 16.121] from use as a flavouring substance is 24 microgram (Table 2a). 
                                                     
 
4 EU figure 375 millions. This figure relates to EU population at the time for which production data are 
available, and is consistent (comparable) with evaluations conducted prior to the enlargement of the EU. No 
production data are available for the enlarged EU. 
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3.2. Intake Estimated on the Basis of the Modified TAMDI (mTAMDI) 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values 
is based on the approach used by SCF up to 1995 (SCF, 1995). 
The assumption is that a person may consume a certain amount of flavourable foods and beverages per 
day. 
For the candidate substance spilanthol [FL-no: 16.121] information on food categories and normal and 
maximum use levels5,6 was submitted by the Flavour Industry (Flavour Industry, 2009r). The 
candidate substance is used in flavoured food products divided into the food categories outlined in 
Annex III of the Commission Regulation (EC) No 1565/2000 (EC, 2000a), as shown in Table 3.1. For 
the present calculation of mTAMDI, the reported normal use levels were used. In the case where 
different use levels were reported for different food categories the highest reported normal use level 
was used. 
Table 3.1 Use of the Candidate Substance 
Food 
category 
Description Flavouring used 
01.0 Dairy products, excluding products of category 2 Yes 
02.0 Fats and oils, and fat emulsions (type water-in-oil) No 
03.0 Edible ices, including sherbet and sorbet Yes 
04.1 Processed fruits Yes 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and 
legumes), and nuts & seeds 
No 
05.0 Confectionery Yes 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses 
& legumes, excluding bakery 
Yes 
07.0 Bakery wares No 
08.0 Meat and meat products, including poultry and game No 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  Yes 
10.0 Eggs and egg products No 
11.0 Sweeteners, including honey No 
12.0 Salts, spices, soups, sauces, salads, protein products etc. Yes 
13.0 Foodstuffs intended for particular nutritional uses No 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products Yes 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts Yes 
15.0 Ready-to-eat savouries Yes 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not 
be placed in categories 1 – 15 
Yes 
 
According to the Flavour Industry the normal use levels for the candidate substance are in the range of 
0.25 - 10 mg/kg food, and the maximum use levels are in the range of 1 - 25 mg/kg (Flavour Industry, 
2009r) (see Table II.1.2, Annex II). 
The mTAMDI value is 830 microgram/person/day for the candidate substance from structural class III 
(see Section 5).  
                                                     
 
5 ”Normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th percentile of reported 
usages (EFFA, 2002i). 
6 The normal and maximum use levels in different food categories (EC, 2000) have been extrapolated from figures derived 
from 12 model flavouring substances (EFFA, 2004e). 
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For detailed information on use levels and intake estimations based on the mTAMDI approach, see 
Section 6 and Annex II. 
4. Absorption, Distribution, Metabolism and Elimination 
Specific information regarding absorption, distribution, metabolism and excretion is not available for 
the candidate substance.  
The candidate substance is like other aliphatic amides anticipated to be absorbed from the 
gastrointestinal tract. Aliphatic amides are expected to be at least partly hydrolysed (Bray et al., 1949) 
to polar metabolites which are eliminated in the urine or bile (James, 1974; Schwen, 1982). Hydrolysis 
of the amide bond is reported as a metabolic pathway for amides e.g. dihydrocapsaicin and piperine in 
vivo in rats. However, complete hydrolysis of the candidate substance to innocuous metabolites cannot 
be anticipated (Kawada & Iwai, 1985; Bhat & Chandrasekhara, 1987). 
5. Application of the Procedure for the Safety Evaluation of Flavouring Substances 
The application of the Procedure is based on intakes estimated on the basis of the MSDI approach. 
Where the mTAMDI approach indicates that the intake of a flavouring substance might exceed its 
corresponding threshold of concern, a formal safety assessment is not carried out using the Procedure. 
In these cases the Panel requires more precise data on use and use levels. For comparison of the intake 
estimations based on the MSDI approach and the mTAMDI approach, see Section 6. 
For the safety evaluation of the candidate substance spilanthol [FL-no: 16.121] from chemical group 
30 the Procedure as outlined in Annex I was applied, based on the MSDI approach. The stepwise 
evaluation of the substance is summarised in Table 2a. 
Step 1 
The candidate substance spilanthol [FL-no: 16.121] is classified according to the decision tree 
approach by Cramer et al. (Cramer et al., 1978) into structural class III. 
Step 2 
The candidate substance cannot be anticipated to be metabolised to innocuous products and thus the 
evaluation proceeds via the B-side of the Procedure scheme. 
Step B3 
The estimated daily per capita intake of the candidate substance is 24 micrograms, which is below the 
threshold for its structural class of 90 micrograms/person/day (class III). Accordingly, the evaluation 
of the substance proceeds to step B4 of the Procedure. 
Step B4 
For the candidate substance and the three supporting substances, the only available toxicity study is a 
28-day oral feeding study in rats with chemical undefined materials. The Panel does not consider this 
study appropriate for deriving a No Observed Adverse Effect Level (NOAEL) to be used at step B4 of 
the Procedure for the candidate substance [FL-no: 16.121], and accordingly additional data are 
required. 
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6. Comparison of the Intake Estimations Based on the MSDI Approach and the mTAMDI 
Approach 
The estimated intake of the candidate substance spilanthol [FL-no: 16.121] assigned to structural class 
III, based on the mTAMDI, is 830 micrograms/person/day, which is above the threshold of concern 
for structural class III of 90 micrograms/person/day. 
Thus, for the candidate substance further information is required. This would include more reliable 
intake data and then, if required, additional toxicological data. 
For comparison of the MSDI and mTAMDI values, see Table 6.1 
 
Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no EU Register name MSDI 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
16.121 Spilanthol 24 830 Class III 90 
7. Considerations of Combined Intakes from Use as Flavouring Substances 
Because of structural similarities of candidate and supporting substances, it can be anticipated that 
many of the flavourings are metabolised through the same metabolic pathways and that the 
metabolites may affect the same target organs. Further, in case of combined exposure to structurally 
related flavourings, the pathways could be overloaded. Therefore, combined intake should be 
considered. As flavourings not included in this FGE may also be metabolised through the same 
pathways, the combined intake estimates presented here are only preliminary. Currently, the combined 
intake estimates are only based on MSDI exposure estimates, although it is recognised that this may 
lead to underestimation of exposure. After completion of all FGEs, this issue should be readdressed. 
The total estimated combined daily per capita intake of structurally related flavourings is estimated by 
summing the MSDI for individual substances. 
On the basis of the reported annual production volume in Europe (Flavour Industry, 2009r), the 
estimated daily per capita intake as flavouring of the candidate substance spilanthol [FL-no: 16.121] 
belonging to structural class III is 24 micrograms. This value does not exceed the threshold of concern 
for structural class III of 90 micrograms/person/day.  
The candidate substance is structurally related to three supporting substances evaluated by the JEFCA 
at its 65th meeting (JECFA, 2006b). Based on reported production volumes, European per capita 
intakes (MSDI) could be estimated for the three supporting substances, deca-(2E,4E)-dienioc acid 
isobutyl-amide [FL-no: 16.091], N-cyclopropyl (2E,6Z)-nonadienamide [FL-no: 16.093] and N-ethyl 
(2E,6Z)-nonadienamide [FL-no: 16.094]. The total combined intake of the candidate and supporting 
substances is approximately 150 micrograms/capita/day, which exceed the thresholds of concern for 
structural class III substances. 
However, the Panel agreed that the intake of about 24 micrograms/capita/day for the candidate 
substance is minor compared to the combined intake of about 126 micrograms/capita/day of the 
supporting substances and that at the level of exposure resulting from the use as flavourings, the 
candidate and supporting substances are expected to be metabolised and would not be expected to 
saturate the metabolic pathways. 
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8. Toxicity 
8.1. Acute Toxicity 
No data are available for the candidate substance or supporting substances.  
8.2. Subacute, Subchronic, Chronic and Carcinogenicity Studies 
Subacute toxicity data are available for the candidate substance spilanthol [FL-no: 16.121] but not for 
the supporting substances of the present flavouring group. 
Only a summary is available on a 28-day study in rats. In the study, groups of five male and five 
female Sprague-Dawley Aai:N(SD)BR rats were maintained on a diet containing 0, 130, 1300 or 
13000 ppm gold root extract of unknown purity. As spilanthol comprises approximately 50% of the 
composition of gold root extract, the effective dietary concentration of spilanthol was about 5.5, 57 
and 572 mg/kg body weight (bw)/day for males and 6.5, 64 and 629 mg/kg bw/day for females, 
respectively. The animals were observed daily for clinical signs and mortality. Individual body 
weights and food consumption were recorded weekly. On day 29 of the study, blood was sampled 
from all animals for haematological and clinical chemistry analysis, and gross necropsis were 
performed on all rats. During the study, no deaths or clinical signs of toxicity were observed in any 
test group. The authors concluded that the NOAEL for spilanthol was 572 mg/kg bw/day based on the 
assumption of the concentration above (Moore, 2002). This result was used at the JECFA evaluation 
of three supporting substances [FL-no: 16.091, 16.093 and 16.094]. However, the Panel does not 
consider this study appropriate for deriving a NOAEL for chronic effects to be used at step B4 of the 
Procedure for these substances, and accordingly additional data are required. According to the practice 
of the Panel, a minimum requirement to provide an adequate NOAEL for flavourings in the Procedure 
is a 90-day study. 
A search in open literature did not reveal further toxicity data on the candidate substance. 
Repeated dose toxicity data are summarised in Annex IV, Table IV.2. 
8.3. Developmental / Reproductive Toxicity Studies 
No data on developmental toxicity and reproductive toxicity are available for the candidate substance 
or supporting substances. 
8.4. Genotoxicity Studies 
No in vitro or in vivo data are available for the candidate substance spilanthol. However, for two of the 
supporting substances [FL-no: 16.091 and 16.093] negative genotoxicity studies are available. The 
Panel therefore also considers that for the candidate substance spilanthol [FL-no: 16.121] the lack of 
genotoxicity data does not preclude the evaluation of this aliphatic amide using the Procedure.  
Genotoxicity data are summarised in Annex IV, Table IV.4. 
9. Conclusions 
The candidate substance spilanthol [FL-no: 16.121] is a branched chain unsaturated aliphatic amide 
from chemical group 30. 
The substance has been presented with specification of the stereoisomeric composition. 
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The candidate substance was assigned to structural class III, according to the decision tree approach 
presented by Cramer et al., 1978. 
According to the Flavour Industry spilanthol has been identified in the plant Spilanthes oleracea, 
which is used in some countries as a spice. 
Genotoxicity data are not available for the candidate substance spilanthol [FL-no: 16.121]. However, 
the Panel considers that the lack of genotoxicity data do not preclude the evaluation of this aliphatic 
amide by using the Procedure. 
The candidate substance cannot be anticipated to be metabolised to innocuous products. 
According to the default MSDI approach, the candidate substance in this group has an intake in 
Europe of 24 micrograms/capita/day [FL-no: 16.121]. For the candidate substance, this is below the 
threshold of concern value for structural class III (90 micrograms/person/day). 
When the estimated intake was based on the mTAMDI approach it is 830 micrograms/person/day for 
the candidate substance from structural class III, which is above the threshold of concern for structural 
III of 90 micrograms/person/day. Therefore more reliable exposure data are required. On the basis of 
such additional data, the flavouring substance should be reconsidered using the Procedure. 
Subsequently, additional data might become necessary. 
No relevant data on toxicity are available for the candidate substance or the three supporting 
substances. The only toxicity data available is a 28-day study which is not considered sufficient to 
evaluate chronic effects of the substance. Accordingly, additional data are required for the candidate 
substance. According to the practice of the Panel, a minimum requirement to provide an adequate 
NOAEL for flavourings in the Procedure is a 90-day study. 
In order to determine whether the conclusion for the candidate substance can be applied to the material 
of commerce, it is necessary to consider the available specifications. Adequate specifications including 
complete purity criteria and identity for the material of commerce have been provided for the 
flavouring substance.  
In conclusion, for the candidate substance spilanthol [FL-no: 16.121] additional data on chemical 
defined material are required as a 28 day study is not considered sufficient to deriving a NOAEL.  
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TABLE 1: SPECIFICATION SUMMARY OF THE SUBSTANCES IN THE FLAVOURING GROUP EVALUATION 303 
Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 303 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
Specification comments 
16.121 
 
Spilanthol 
N
H
O
 
4668 
 
25394-57-4 
Liquid 
C14H23NO 
221.35 
Not soluble 
Soluble 
140-160 (13 Pa) 
 
IR NMR MS 
74 % 
1.4911-1.5411 
0.9452-0.9468 
 
Synonym: (2E,6Z,8E)-N-(2-Methylpropyl)-
2,6,8-decatrienamide. Mixture of isomers: 
74.007 % (2E,6Z,8E)-, 16.669 % 
(2E,6E,8E)-, 5.759 % (2E,6E,8Z)-, 0.884 % 
(2Z,6Z,8E)-, 0.334 % (2E,6E,8E)-, 0.764 % 
(2Z,6Z,8Z)-isomer, 1.553 % other isomers.  
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 %  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
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TABLE 2A : SUMMARY OF SAFETY EVALUATION APPLYING THE PROCEDURE (BASED ON INTAKES CALCULATED BY THE MSDI APPROACH) 
Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) (μg/capita/day) Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), or 
8)] 
Evaluation remarks 
16.121 
 
Spilanthol 
N
H
O
24 
 
Class III 
B3: Intake below threshold,  
B4: No adequate NOAEL 
Additional data required 6)  
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
6) No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 1 (based on intake calculated by the MSDI approach). 
7) Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8) No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
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TABLE 2B: EVALUATION STATUS OF HYDROLYSIS PRODUCTS OF CANDIDATE SUBSTANCES (BASED ON INTAKES CALCULATED BY THE MSDI 
APPROACH) 
Table 2b: Evaluation Status of Hydrolysis Products of Candidate Substances 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
 2,6,8-Triendecanoic acid 
OH
O Not evaluated as flavouring substance Not evaluated as flavouring substance Not evaluated as flavouring substance. 
11.002 Isobutylamine 
1583 NH2  
 
No safety concern a) 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
1) Category 1: Considered safe in use   Category 2: Temporarily considered safe in use   Category 3: Insufficient data to provide assurance of safety in use   Category 4): Not acceptable due to evidence of toxicity. 
2) No safety concern at estimated levels of intake. 
3) Category A: Flavouring substance, which may be used in foodstuffs Category B: Flavouring substance which can be used provisionally in foodstuffs. 
4) Threshold of concern: Class I = 1800, Class II = 540, Class III = 90 µg/person/day. 
5) Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot. 
a) (JECFA, 2008d). 
b) (CoE, 1992). 
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TABLE 3: SUPPORTING SUBSTANCES SUMMARY 
Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
EFSA Comments 
16.091 Deca-(2E,4E)-dienoic acid 
isobutyl-amide 
N
H
O  
 
18836-52-7 
1598 
JECFA specification (JECFA, 
2005d) 
6.1  
No safety concern a) 
 
EFSA conclusion: B4-No, 
additional data required 
(EFSA, 2008ar). 
16.093 N-Cyclopropyl (2E,6Z)-
nonadienamide 
N
H
O
 
 
 
608514-55-2 
1597 
JECFA specification (JECFA, 
2005d) 
61  
No safety concern a) 
 
EFSA conclusion: B4-No, 
additional data required 
(EFSA, 2008ar). 
16.094 N-Ethyl (2E,6Z)-
nonadienamide 
N
H
O
 
 
 
608514-56-3 
1596 
JECFA specification (JECFA, 
2005d) 
61  
No safety concern a) 
 
EFSA conclusion: B4-No, 
additional data required 
(EFSA, 2008ar). 
1) EU MSDI: Amount added to food as flavouring substance in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Category 1: Considered safe in use, Category 2: Temporarily considered safe in use, Category 3: Insufficient data to provide assurance of safety in use, Category 4: Not acceptable due to evidence of toxicity. 
3) No safety concern at estimated levels of intake. 
4) Category A: Flavouring substance, which may be used in foodstuffs, Category B: Flavouring substance which can be used provisionally in foodstuffs. 
a) (JECFA, 2008d). 
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ANNEX I: PROCEDURE FOR THE SAFETY EVALUATION 
The approach for a safety evaluation of chemically defined flavouring substances as referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), named the "Procedure", is shown in schematic 
form in Figure I.1. The Procedure is based on the Opinion of the Scientific Committee on Food expressed on 
2 December 1999 (SCF, 1999a), which is derived from the evaluation Procedure developed by the Joint 
FAO/WHO Expert Committee on Food Additives at its 44th, 46th and 49th meetings (JECFA, 1995; JECFA, 
1996a; JECFA, 1997a; JECFA, 1999b). 
The Procedure is a stepwise approach that integrates information on intake from current uses, structure-
activity relationships, metabolism and, when needed, toxicity. One of the key elements in the Procedure is 
the subdivision of flavourings into three structural classes (I, II, III) for which thresholds of concern (human 
exposure thresholds) have been specified. Exposures below these thresholds are not considered to present a 
safety concern. 
Class I contains flavourings that have simple chemical structures and efficient modes of metabolism, which 
would suggest a low order of oral toxicity. Class II contains flavourings that have structural features that are 
less innocuous, but are not suggestive of toxicity. Class III comprises flavourings that have structural 
features that permit no strong initial presumption of safety, or may even suggest significant toxicity (Cramer 
et al., 1978). The thresholds of concern for these structural classes of 1800, 540 or 90 
micrograms/person/day, respectively, are derived from a large database containing data on subchronic and 
chronic animal studies (JECFA, 1996a). 
In Step 1 of the Procedure, the flavourings are assigned to one of the structural classes. The further steps 
address the following questions: 
• can the flavourings be predicted to be metabolised to innocuous products7 (Step 2)?  
• do their exposures exceed the threshold of concern for the structural class (Step A3 and B3)? 
• are the flavourings or their metabolites endogenous8 (Step A4)?  
• does a NOAEL exist on the flavourings or on structurally related substances (Step A5 and B4)? 
In addition to the data provided for the flavouring substances to be evaluated (candidate substances), 
toxicological background information available for compounds structurally related to the candidate 
substances is considered (supporting substances), in order to assure that these data are consistent with the 
results obtained after application of the Procedure.  
The Procedure is not to be applied to flavourings with existing unresolved problems of toxicity. Therefore, 
the right is reserved to use alternative approaches if data on specific flavourings warranted such actions. 
 
                                                     
 
7 “Innocuous metabolic products”: Products that are known or readily predicted to be harmless to humans at the 
estimated intakes of the flavouring agent” (JECFA, 1997a). 
 
8 “Endogenous substances”: Intermediary metabolites normally present in human tissues and fluids, whether free or 
conjugated; hormones and other substances with biochemical or physiological regulatory functions are not included 
(JECFA, 1997a). 
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Decision tree structural class 
Can the substance be predicted to be metabolised to innocuous products?
Procedure for Safety Evaluation of Chemically Defined Flavouring Substances 
Do the conditions of use result in an intake greater than the 
threshold of concern for the structural class?
Do the conditions of use result in an intake greater than the  
threshold of concern for the structural class? 
Data must be available on the  
substance or closely related  
substances to perform a safety 
evaluation
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is  high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
  Substance would not be    
expected to be of safety concern
Is the substance or are its metabolites endogenous?
Additional data required 
Step 1. 
Step 2. 
Step A3. 
Step A4. 
Step A5. 
Step B3. 
Step B4.
 Yes No
 Yes 
 No 
No
No
Yes
No
Yes
Yes
Yes
 No
Figure I.1 Procedure for Safety Evaluation of Chemically Defined Flavouring Substances
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ANNEX II: USE LEVELS / MTAMDI 
II.1 Normal and Maximum Use Levels 
For each of the 18 Food categories (Table II.1.1) in which the candidate substances are used, Flavour 
Industry reports a “normal use level” and a “maximum use level” (EC, 2000a). According to the Industry the 
”normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th 
percentile of reported usages (EFFA, 2002i). The normal and maximum use levels in different food 
categories have been extrapolated from figures derived from 12 model flavouring substances (EFFA, 2004e). 
Table II.1.1 Food categories according to Commission Regulation (EC) No 1565/2000 (EC, 2000a) 
Food category Description 
01.0 Dairy products, excluding products of category 02.0 
02.0 Fats and oils, and fat emulsions (type water-in-oil) 
03.0 Edible ices, including sherbet and sorbet 
04.1 Processed fruit 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds 
05.0 Confectionery 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, excluding bakery 
07.0 Bakery wares 
08.0 Meat and meat products, including poultry and game 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  
10.0 Eggs and egg products 
11.0 Sweeteners, including honey 
12.0 Salts, spices, soups, sauces, salads, protein products, etc. 
13.0 Foodstuffs intended for particular nutritional uses 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts 
15.0 Ready-to-eat savouries 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed in categories 01.0 - 15.0 
 
The “normal and maximum use levels” are provided by Industry for the one candidate substance, spilanthol 
[FL-no: 16.121] in the present flavouring group (Table II.1.2). 
Table II.1.2 Normal and Maximum use levels (mg/kg) for the candidate substance in FGE.303 (Flavour 
Industry, 2009r). 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
16.121 1,25 
2,5 
- 
- 
1,25 
2,5 
0,25 
1 
- 
- 
10 
17,5 
1 
3 
- 
- 
- 
- 
0,5 
1,5 
- 
- 
- 
- 
0,75 
1,5 
- 
- 
0,5 
1,5 
1 
3 
10 
25 
1 
3 
II.2 mTAMDI Calculations 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values is 
based on the approach used by SCF up to 1995 (SCF, 1995). The assumption is that a person may consume 
the amount of flavourable foods and beverages listed in Table II.2.1. These consumption estimates are then 
multiplied by the reported use levels in the different food categories and summed up.  
Table II.2.1 Estimated amount of flavourable foods, beverages, and exceptions assumed to be consumed per 
person per day (SCF, 1995) 
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Class of product category Intake estimate (g/day) 
Beverages (non-alcoholic) 324.0 
Foods 133.4 
Exception a: Candy, confectionery 27.0 
Exception b: Condiments, seasonings 20.0 
Exception c: Alcoholic beverages 20.0 
Exception d: Soups, savouries 20.0 
Exception e: Others, e.g. chewing gum e.g. 2.0 (chewing gum) 
 
The mTAMDI calculations are based on the normal use levels reported by Industry. The seven food 
categories used in the SCF TAMDI approach (SCF, 1995) correspond to the 18 food categories as outlined in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a) and reported by the Flavour Industry in the 
following way (see Table II.2.2): 
• Beverages (SCF, 1995) correspond to food category 14.1 (EC, 2000a) 
• Foods (SCF, 1995) correspond to the food categories 1, 2, 3, 4.1, 4.2, 6, 7, 8, 9, 10, 13, and/or 16 
(EC, 2000a) 
• Exception a (SCF, 1995) corresponds to food category 5 and 11 (EC, 2000a) 
• Exception b (SCF, 1995) corresponds to food category 15 (EC, 2000a) 
• Exception c (SCF, 1995) corresponds to food category 14.2 (EC, 2000a) 
• Exception d (SCF, 1995) corresponds to food category 12 (EC, 2000a) 
• Exception e (SCF, 1995) corresponds to others, e.g. chewing gum. 
Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995) 
 Food categories according to Commission Regulation (EC) No1565/2000 Distribution of the seven SCF food categories 
Key Food category Food Beverages Exceptions 
01.0 Dairy products, excluding products of category 02.0 Food   
02.0 Fats and oils, and fat emulsions (type water-in-oil) Food   
03.0 Edible ices, including sherbet and sorbet Food   
04.1 Processed fruit Food   
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), 
and nuts & seeds 
Food   
05.0 Confectionery   Exception a 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & 
legumes, excluding bakery 
Food   
07.0 Bakery wares Food   
08.0 Meat and meat products, including poultry and game Food   
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  Food   
10.0 Eggs and egg products Food   
11.0 Sweeteners, including honey   Exception a 
12.0 Salts, spices, soups, sauces, salads, protein products, etc.    Exception d 
13.0 Foodstuffs intended for particular nutritional uses Food   
14.1 Non-alcoholic ("soft") beverages, excl. dairy products  Beverages  
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts   Exception c 
15.0 Ready-to-eat savouries   Exception b 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be 
placed in categories 01.0 - 15.0 
Food   
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The mTAMDI values (see Table II.2.3) are presented for the candidate substance in the present flavouring 
group, for which Industry has provided use and use levels (Flavour Industry, 2009r). The mTAMDI values 
are only given for the highest reported normal use levels. 
TableII.2.3 Estimated intakes based on the mTAMDI approach 
FL-no EU Register name mTAMDI 
(μg/person/day) 
Structural class Threshold of concern 
(µg/person/day) 
16.121 Spilanthol 830 Class III 90 
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ANNEX III: METABOLISM 
Specific information regarding absorption, distribution, metabolism and excretion is not available for the 
candidate substance.  
The candidate substance is like other aliphatic amides anticipated being absorbed from the gastrointestinal 
tract. Aliphatic amides are expected to be at least partly hydrolysed (Bray et al., 1949) to polar metabolites 
which are eliminated in the urine or bile (James, 1974; Schwen, 1982). Hydrolysis of the amide bond is 
reported as a metabolic pathway for amides e.g. dihydrocapsaicin and piperine in vivo in rats, however, 
complete hydrolysis of the candidate substance cannot be anticipated (Kawada & Iwai, 1985; Bhat & 
Chandrasekhara, 1987). 
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ANNEX IV: TOXICITY 
ACUTE TOXICITY 
No oral acute toxicity data are available for the candidate substance of the present Flavouring Group Evaluation from chemical group 30, nor for the 
supporting substances evaluated by the JECFA at the 65th meeting (JECFA, 2006d).  
 
SUBACUTE, SUBCRONIC, CHRONIC AND CARCINOGENIC TOXICITY STUDIES 
Subacute / Subchronic / Chronic / Carcinogenic toxicity data are available for the candidate substance of the present Flavouring Group Evaluation from 
chemical group 30 but not for the supporting substances evaluated by the JECFA at the 65th meeting (JECFA, 2006d). 
TABLE IV.2: SUBACUTE / SUBCHRONIC / CHRONIC / CARCINOGENICITY STUDIES 
Chemical Name [FL-no] Species; Sex 
No./Group 
Route Dose levels Duration NOAEL 
(mg/kg bw/day) 
Reference Comments 
Spilanthol [16.121] Rats, M, F 
5 
Oral M: 5.5, 57, 572 mg/kg 
bw/day 
F: 6.5, 64, 629 mg/kg 
bw/day 
28 days 572 (Moore, 2002) The study is not considered valid. 
The study has not been available. Only a short summary has been submitted by 
Industry. The JECFA evaluation of this study at the 65th meeting has also been 
considered but the Panel did not agree with the JECFA that the study is 
appropiate for deriving a NOAEL.  
 
DEVELOPMENTAL AND REPRODUCTIVE TOXICITY 
No developmental and reproductive toxicity data are available for the candidate substance of the present Flavouring Group Evaluation from chemical group 30 
or for the supporting substances evaluated by the JECFA at the 65th meeting (JECFA, 2006d). 
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GENOTOXICITY (IN VITRO) 
No in vitro mutagenicity/genotoxicity data are available for the candidate substance of the present Flavouring Group Evaluation from chemical group 30 but 
for two supporting substances evaluated by the JECFA at the 65th meeting (JECFA, 2006d).  
TABLE IV.4: GENOTOXICITY (IN VITRO) 
Chemical Name [FL-no] Test System Test Object Concentration 
 
Result Reference Comments 
(Deca-(2E,4E)-dienoic acid 
isobutyl-amide [16.091]) 
Reverse Mutation Salmonella typhimurium TA98, TA100, TA102, TA1535, TA1537 5 to 1500 µg/plate3 Negative1 (King, 2003)  
 Reverse Mutation S.typhimurium TA98, TA100, TA102, TA1535, TA1537 5 to 5000 µg/plate4 Negative2 (King, 2003)  
(N-Cyclopropyl (2E,6Z)-
nonadienamide [16.093]) 
Reverse Mutation S.typhimurium TA98, TA100, TA1535, TA1537 Up to 5000 µg/plate Negative1 (Bowles, 2003)  
 Reverse Mutation E.coli WP2 uvrA- Up to 5000 µg/plate Negative1 (Bowles, 2003)  
1 With and without S9 metabolic activation. 
2 With metabolic activation. 
3 Toxic and precipitates at 1,500 µg/plate. 
4 Toxic and precipitates at 5,000 µg/plate. 
 
GENOTOXICITY (IN VIVO) 
No in vivo mutagenicity/genotoxicity data are available for the candidate substance of the present Flavouring Group Evaluation from chemical group 30 nor 
for the supporting substances evaluated by the JECFA at the 65th meeting (JECFA, 2006d). 
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ABBREVIATIONS 
ADI  Acceptable Daily Intake 
BW  Body Weight 
CAS  Chemical Abstract Service 
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
Chemical Abstract Service 
CoE  Council of Europe 
EC  European Commission 
EFFA  European Flavour and Fragrance Association 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
ID   Identity 
IOFI  International Organization of the Flavour Industry 
IR   Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
MS  Mass spectrometry 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NMR  Nuclear Magnetic Resonance 
No  Number 
NOAEL No Observed Adverse Effect Level 
NTP  National Toxicology Program 
SCF  Scientific Committee on Food 
TAMDI Theoretical Added Maximum Daily Intake 
WHO  World Health Organisation  
